Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 6-K Current report (foreign)
- 99.1 Inflarx N.V. Unaudited Condensed Consolidated Financial Statements As of and for the Three and Six Months Ended June 30, 2023
- 99.2 Inflarx N.V. Management's Discussion and Analysis of Financial Condition and Results of Operations
- 99.3 Inflarx N.V. Press Release Dated August 10, 2023
- Download Excel data file
- View Excel data file
IFRX similar filings
- 1 Nov 23 Current report (foreign)
- 11 Sep 23 InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904
- 30 Aug 23 Current report (foreign)
- 10 Aug 23 Report of Foreign Private Issuer
- 28 Jun 23 InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
- 21 Jun 23 InflaRx Announces Commercial Launch of Gohibic (vilobelimab) in the U.S. for the Treatment of Critically Ill COVID-19 Patients
- 11 May 23 Current report (foreign)
Filing view
External links